Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-021296
Filing Date
2024-02-27
Accepted
2024-02-27 16:54:30
Documents
6
Effectiveness Date
2024-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 rgnx-s8-2024-02-27.htm S-8 74351
2 EX-5.1 rgnx-ex5_1.htm EX-5.1 9040
3 EX-23.1 rgnx-ex23_1.htm EX-23.1 4013
4 EX-FILING FEES rgnx-exfiling_fees.htm EX-FILING FEES 29734
5 GRAPHIC img252287865_0.jpg GRAPHIC 4667
6 GRAPHIC img252287865_1.jpg GRAPHIC 3413
  Complete submission text file 0000950170-24-021296.txt   129762
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277412 | Film No.: 24687949
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)